The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
1 marketed package NDCs · 1 active manufacturer
Most dispensed: 10 mg/5mL; 100 mg/5mL · Syrup · #237 mL/bottle, plastic · 600 mg; 30 mg · Tablet, Extended Release · #2 blister packs/carton / 20 tablet, extended release in 1 blister pack · 600 mg; 30 mg · Tablet, Extended Release · #1 blister pack/carton / 20 tablet, extended release in 1 blister pack · 600 mg; 30 mg · Tablet, Extended Release · #1 pouch/carton / 2 tablet, extended release in 1 pouch
Only one company currently supplies this market — there is no backup if it stumbles.
Every detected change for guaifenesin and dextromethorphan hydrobromide, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Other molecules FDA puts in Uncompetitive N-methyl-D-aspartate Receptor Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.